FVSKX
Price
$50.06
Change
+$0.14 (+0.28%)
Updated
May 9 closing price
Net Assets
1.67B
JVMCX
Price
$24.96
Change
+$0.08 (+0.32%)
Updated
May 9 closing price
Net Assets
20.83B
Ad is loading...

FVSKX vs JVMCX

Header iconFVSKX vs JVMCX Comparison
Open Charts FVSKX vs JVMCXBanner chart's image
Fidelity Value Strategies K
Price$50.06
Change+$0.14 (+0.28%)
VolumeN/A
Net Assets1.67B
JHancock Disciplined Value Mid Cap C
Price$24.96
Change+$0.08 (+0.32%)
VolumeN/A
Net Assets20.83B
FVSKX vs JVMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FVSKX vs. JVMCX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FVSKX is a Buy and JVMCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 20.8B vs. FVSKX (1.67B). FVSKX pays higher dividends than JVMCX: FVSKX (0.37) vs JVMCX (0.00). FVSKX was incepted earlier than JVMCX: FVSKX (17 years) vs JVMCX (14 years). JVMCX (1.88) is less costly to investors than FVSKX (0.72). FVSKX is a more actively managed with annual turnover of: 61.00 vs. JVMCX (47.00). FVSKX has a lower initial minimum investment than JVMCX: FVSKX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : -9.46 vs. FVSKX (-14.57). FVSKX return over 5 years is better than : 77.13 vs. JVMCX (47.59).
FVSKXJVMCXFVSKX / JVMCX
Total Expense Ratio0.721.8739%
Annual Report Gross Expense Ratio0.721.8838%
Fund Existence17 years14 years-
Gain YTD-9.054-1.660545%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.67B20.8B8%
Annual Yield % from dividends0.370.00-
Returns for 1 year-14.57-9.46154%
Returns for 3 years6.073.55171%
Returns for 5 years77.1347.59162%
Returns for 10 years13.6021.6263%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TFC39.01-0.03
-0.08%
Truist Financial Corp
JHG36.36-0.10
-0.27%
Janus Henderson Group plc
SPRY13.44-0.05
-0.37%
ARS Pharmaceuticals
RYAM3.63-0.13
-3.46%
Rayonier Advanced Materials
AKTX1.26-0.08
-5.96%
Akari Therapeutics plc